CRO/Sponsor

Survey from the Site Council gathered insights from its members on the quality of site coordinator work.

Addressing data integrity and compliance concerns.

This year’s conference highlighted a number of critical areas in clinical R&D including financial management, representation, and eCOA.

Examining those technology-supported areas that sponsors, CROs, and sites consider the most valuable.

Insights identify opportunities to optimize sponsor, CRO, and site collaborations.

Clinical trial liaisons rather serve as experts in their therapeutic areas and as clinical trial specialists to provide a suite of strategic advantages to benefit a study.

A focus on data and process excellence advances product development.

How a deeper review of site budget and payment processes and technology is driving meaningful change in the industry.

Strategies for sponsors to utilize technology in reaching diverse patient populations.

Balancing these tools with operational efficiencies can aid CROs in meeting the evolving needs of sponsors.

Use cases spotlight the growing potential of generative AI in the CRO space.

A well-designed approach can benefit clinical trials from protocol design to site support.

Palmese, executive director, site relationships and DCT solutions, discusses the practice of incorporating decentralized elements in a study rather than planning a decentralized trial from the start.

Sponsors and CROs that work with these sites can better reach marginalized communities.

Results from survey of 100 site personnel suggest a disconnect is present between these stakeholders.

It takes a village to raise a trial, but most stakeholders are siloed on isolated islands.

In a fireside chat with ACT editor Andy Studna, Bowdish, from a clinical research cancer center, shares her experience with these relationships and how to streamline clinical operations.

Use case explores the arrangement’s effectiveness in the biometrics setting.

A data-fueled framework for sponsors and CROs in navigating this shifting terrain.

In this video interview with ACT editor Andy Studna, Mwango Kashoki, SVP, global head of regulatory strategy, Parexel, touches on challenges that may be created by the guidance such as meeting multiple regulatory requirements.

In this video interview with ACT editor Andy Studna, Mwango Kashoki, SVP, global head of regulatory strategy, Parexel, discusses how sponsors will need to plan ahead even further for their oncology trials.

CRO-sponsor relationships are key as industry moves towards new age of outsourcing.

Webinar Date/Time: Thu, Oct 24, 2024 1:00 PM EDT

In an interview with Applied Clinical Trials Associate Editor Don Tracy, Sonia Lwoff, director, clinical operations, Rho, discusses the importance of CROs building strong relationships with trial sites.

Webinar Date/Time: Wed, Sep 25, 2024 11:00 AM EDT

Webinar Date/Time: Wednesday, September 25th, 2024 at 10am EDT | 7am PDT | 3pm BST | 4pm CEST

Webinar Date/Time: Wednesday, September 11th, 2024 at 11am EDT|8am PDT|4pm BST|5pm CEST

Webinar Date/Time: Tuesday, September 10th, 2024 at 11am EDT|8am PDT|4pm BST|5pm CEST

Webinar Date/Time: Tue, Aug 20, 2024 11:00 AM EDT

With investors embracing the new regulations, a look at the progress CROs are making in their sustainability efforts